Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayNov 15, 2021 8:30 am

The Lift & Co. Expo, Largest Industry and Consumer Cannabis Event in Canada, Set to Attract Consumers, Professionals, and the Media This year

Date: November 18-21, 2021  Metro Toronto Convention Center, North Building 255 Front St W The Lift & Co. Expo will be making a comeback in Toronto following a one-year halt. It promises to be better than ever before, offering value to all stakeholders within the cannabis and psychedelics space, from consumers to professionals and business owners. The event builds on Lift & Co.’s previous successful events while taking it a step further. Over 1000 attendees are expected to show up, and over 250 exhibitors have confirmed their participation. This guarantees an opportunity to build brand awareness, explore global expansion opportunities,…

Continue Reading

MondayNov 15, 2021 8:30 am

Hero Technologies Inc. (HENC) Committed to Safety as Michigan Legislators Look to Restrict Caregiver Cultivation in Growing Market

Michigan lawmakers approve bills designed to restrict medical marijuana cultivation by caregivers Marijuana sales in the state are increasing. Top priority is concern about the safety of untested medical marijuana grown by caregivers. With Michigan seeing record sales this year, the state is looking to provide regulation over the growing market in efforts to ensure quality and safety. Recently, Michigan lawmakers approved bills designed to restrict medical marijuana cultivation by caregivers (https://nnw.fm/c94wD). Growth and legislation are key points that cannabis company Hero Technologies (OTC: HENC) is paying close attention to, as the company works to strengthen its presence in the state’s…

Continue Reading

MondayNov 15, 2021 8:30 am

Cannabis Strategic Ventures Inc. (NUGS) Inks MOU Outlining Strategic Acquisition of Indoor Cannabis Cultivation Facility

Cannabis sales are projected to increase as NUGS makes move to increase premium cannabis production MOU grants rights for NUGS to purchase 10% of the facility at a valuation of $15 million for the entire facility Agreement strengthens company’s status as an emerging leader in the vertically integrated California cannabis marketplace As sales of high-quality cannabis in California, the largest cannabis market in the country, are projected to increase, Cannabis Strategic Ventures (OTCQB: NUGS) is taking strategic steps to ensure its position in the growing space. Most recently, the company inked a Memorandum of Understanding with Devine Solution Inc. with…

Continue Reading

MondayNov 15, 2021 8:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Is ‘One to Watch’

Mullen Automotive is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life The company commenced trading on the Nasdaq Capital Market on November 5, 2021, following a stock-for-stock merger with Net Element Inc. The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (“LAIAS”) on November 17, 2021, is currently open for reservations The global EV market is forecast to grow at a CAGR of 22.6% through 2027 Mullen is led by CEO and Founder David Michery, a seasoned executive with more than…

Continue Reading

MondayNov 15, 2021 8:00 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) and San Diego XMarket Store Spreading Educational Value of a Plant-Based Lifestyle

PlantX has opened its first United States brick and mortar store in the Hillcrest neighborhood of San Diego, although the company’s earlier acquisition of New Deli, a vegan marketplace opened by Chef Matthew Kenney, resulted in a rebranding of their Venice, California New Deli location as XMarket The partnership between PlantX and Kenney reflects a mission to educate consumers and the public about living a plant-based/vegan lifestyle by offering educational resources in the form of blogs, podcasts, and YouTube videos PlantX features products ranging from food, beverages, pets, personal hygiene, and more, and the company’s XMarket locations also offer local…

Continue Reading

MondayNov 15, 2021 8:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Files Technology Patent Application Covering Bioavailability-Enhancing, Nanoemulsion-Empowered Formulations

Mydecine has filed a technology patent application that allows for the creation of nanoemulsion-empowered formulations to improve, stabilize, and increase the bioavailability of ingredients The company aims to use the nanoemulsion technology to enhance the bioavailability and optimize the delivery of compounds that are inspired by traditional ingredients In September, Mydecine filed its final patent application for MYCO-003, one of its lead drug candidates for enhanced treatment of anxiety and post-traumatic stress disorder MYCOF is steadily strengthening its IP portfolio as it seeks to reimagine the treatment of mental health and addiction Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF), an…

Continue Reading

FridayNov 12, 2021 2:23 pm

Flora Growth Corp. (NASDAQ: FLGC) Expands Its Plant-Based CPG Market Reach, Celebrates International Medical Cannabis Certification

International cannabis cultivator, manufacturer, and distributor of plant-based lifestyle and wellness brands Flora Growth Corp. is steadily building a worldwide pipeline for downstream cannabis brands using its Colombian cultivation facilities and a growing list of trade partners Flora Growth recently announced multiple distribution and e-commerce marketplace agreements that will see its two leading skincare brands, MIND Naturals and Awe (Ô), distributed via GlossWire and Showfields  The company also expects its Colombian on-site CBD extraction facility to come online as well as complete the first harvests of its high-THC psychoactive cultivars later in the month Flora Growth achieved Good Agricultural and…

Continue Reading

FridayNov 12, 2021 1:23 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Embarks on its Most Ambitious Hypertension Clinical Study Yet: HYPER-H21-4

Lexaria has embarked on its HYPER-H21-4 study, its fourth hypertension clinical study, and it's most ambitious yet This study builds on the HYPER-H21-1 and HYPER-H21-2 findings, as well as the HYPER-H21-3 study that is set to begin dosing in mid-November 2021 Lexaria’s goal is to pursue regulatory approval for its proprietary DehydraTECH-CBD for potential use as a treatment for high blood pressure Study protocols are being readied for submission to the IRB, and approval is expected by January 2022 Lexaria Bioscience (NASDAQ: LEXX) has, so far in 2021, embarked on several studies geared towards evaluating its proprietary DehydraTECH(TM) CBD for…

Continue Reading

FridayNov 12, 2021 12:48 pm

The Lift & Co. Expo, Canada’s Number One Cannabis Event, Back in Toronto

Metro Toronto Convention Center, North Building 255 Front St W The Lift & Co. Expo, Canada’s number one cannabis event, makes a comeback this year in Toronto. This four-day event promises to be better than ever before, all while educating, connecting, and growing cannabis consumers, professionals, and media. This event will feature over 250 exhibitors and different forward-thinking speakers, movers and shakers within the industry. It promises to offer attendees top-notch educational content, enrich thought leadership from the industry’s brightest minds, and present fun and authentic networking opportunities. The four-day event will have the Lift Cannabis Conference on the first…

Continue Reading

FridayNov 12, 2021 12:12 pm

Recent Sector News Reveals Positive Data in Psychedelic Treatments For Depression as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Nears Launch of Synthetic Psilocybin Trials

Pharmaceutical company Tryp Therapeutics is developing a proprietary synthetic hallucinogen as potential medical solutions for select unmet health needs, with a focus on taking psychedelic therapeutics beyond mental health The company recently attended the Wonderland: Miami where Compass Pathways unveiled highly anticipated data from their Phase 2b trial in treatment-resistant depression Tryp’s Chairman and CEO Greg McKee served on a panel at Wonderland: Miami discussing the potential of synthetic psilocybin in chronic pain indications and the importance of supporting industry wins  Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) Chairman and CEO Greg McKee recently participated in Microdose’s Wonderland: Miami conference as…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000